Gabapentin and Temsirolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Gabapentin and Temsirolimus. Common interactions include dehydration among females and stomatitis among males.

The phase IV clinical study analyzes what interactions people who take Gabapentin and Temsirolimus have. It is created by eHealthMe based on reports of 53 people who take Gabapentin and Temsirolimus from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Feb, 03, 2023

53 people who take Gabapentin and Temsirolimus together, and have interactions are studied.


What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 273,443 Gabapentin users for its effectiveness, alternative drugs and more.

What is Temsirolimus?

Temsirolimus has active ingredients of temsirolimus. eHealthMe is studying from 3,447 Temsirolimus users for its effectiveness, alternative drugs and more.

Number of Gabapentin and Temsirolimus reports submitted per year:

Gabapentin and Temsirolimus drug interactions.

Common Gabapentin and Temsirolimus drug interactions by gender *:

female:

  1. Dehydration
  2. Enterocolitis
  3. Neutropenia
  4. Platelet count decreased
  5. Stomatitis
  6. Headache
  7. Pericardial effusion
  8. Syncope
  9. Vision blurred
  10. Abdominal pain

male:

  1. Stomatitis
  2. Pharyngeal inflammation
  3. Abdominal pain
  4. Chest pain
  5. Febrile neutropenia
  6. Leukaemia
  7. Lung infection
  8. Neck pain
  9. Neoplasm malignant
  10. Pericarditis

Common Gabapentin and Temsirolimus drug interactions by age *:

0-1:

n/a

2-9:

  1. Dehydration
  2. Diarrhoea
  3. Neuropathy peripheral
  4. Vomiting

10-19:

  1. Stomatitis
  2. Neutropenia
  3. Enterocolitis
  4. Platelet count decreased
  5. Pharyngeal inflammation
  6. Pericardial effusion
  7. Pleural effusion
  8. Pneumonitis
  9. Respiratory failure
  10. Abdominal pain

20-29:

n/a

30-39:

  1. Syncope
  2. Abdominal pain
  3. Nausea
  4. Coccydynia
  5. Unresponsive to stimuli
  6. Disease progression
  7. Dehydration
  8. Musculoskeletal pain

40-49:

  1. Sepsis

50-59:

  1. Chest pain
  2. Arthralgia
  3. Atrioventricular block complete
  4. Back pain
  5. Confusional state
  6. Dehydration
  7. Leukoencephalopathy
  8. Lymphocyte count decreased
  9. Mouth haemorrhage
  10. Myalgia

60+:

  1. Headache
  2. Pericardial effusion
  3. Hip arthroplasty
  4. Oedema peripheral
  5. Post procedural infection
  6. Sudden death
  7. Tenderness
  8. Vision blurred
  9. Cardiac arrest
  10. International normalised ratio increased

Common conditions people have *:

  1. Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 17 people, 32.08%
  2. Pain: 9 people, 16.98%
  3. Renal Cell Carcinoma (a kidney cancer): 6 people, 11.32%
  4. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 5 people, 9.43%
  5. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 9.43%
  6. Constipation: 4 people, 7.55%
  7. Cancer Pain: 4 people, 7.55%
  8. Staphylococcal Bacteraemia (a bacterial infection of blood): 3 people, 5.66%
  9. Squamous Cell Carcinoma (a cancer of a kind of epithelial cell): 3 people, 5.66%
  10. Nausea And Vomiting: 3 people, 5.66%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and Temsirolimus?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Gabapentin and Temsirolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Gabapentin side effects:

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Temsirolimus side effects:

Browse all side effects of Temsirolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Gabapentin interactions:

Browse all interactions between Gabapentin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Temsirolimus interactions:

Browse all interactions between Temsirolimus and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin and temsirolimus (the active ingredients of Gabapentin and Temsirolimus, respectively), and Gabapentin and Temsirolimus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Gabapentin and Temsirolimus.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: